title: A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
authors.forename: L
authors.initials: L
authors.lastname: Grimaldi
authors.forename: F
authors.initials: F
authors.lastname: Barkhof
authors.forename: M
authors.initials: M
authors.lastname: Beelke
authors.forename: J
authors.initials: J
authors.lastname: Burton
authors.forename: T
authors.initials: T
authors.lastname: Holmoy
authors.forename: R
authors.initials: R
authors.lastname: Hupperts
authors.forename: J
authors.initials: J
authors.lastname: Killestein
authors.forename: P
authors.initials: P
authors.lastname: Rieckmann
authors.forename: M
authors.initials: M
authors.lastname: Schluep
authors.forename: J
authors.initials: J
authors.lastname: Smolders
mesh_terms: D015652:25-Hydroxyvitamin D 2 / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D014815:Vitamins / Q000627:therapeutic use*
chemical_list: D014815:Vitamins; D015652:25-Hydroxyvitamin D 2